famotidine has been researched along with Esophageal Varices in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akahoshi, T | 1 |
Kawanaka, H | 1 |
Tomikawa, M | 1 |
Saeki, H | 1 |
Uchiyama, H | 1 |
Ikeda, T | 1 |
Shirabe, K | 1 |
Hashizume, M | 1 |
Maehara, Y | 1 |
Tanaka, J | 1 |
Fujimoto, K | 1 |
Iwakiri, R | 1 |
Koyama, T | 1 |
Sakata, H | 1 |
Ohyama, T | 1 |
Mizuguchi, M | 1 |
Tokunaga, O | 1 |
1 trial available for famotidine and Esophageal Varices
Article | Year |
---|---|
Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
Topics: Aged; Esophageal and Gastric Varices; Esophageal pH Monitoring; Esophagitis, Peptic; Famotidine; Fem | 2013 |
1 other study available for famotidine and Esophageal Varices
Article | Year |
---|---|
Hyperplastic polyps following treatment of acute gastric ulcers.
Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Po | 1994 |